277 related articles for article (PubMed ID: 22072285)
21.
Grayson PC; Alehashemi S; Bagheri AA; Civelek AC; Cupps TR; Kaplan MJ; Malayeri AA; Merkel PA; Novakovich E; Bluemke DA; Ahlman MA
Arthritis Rheumatol; 2018 Mar; 70(3):439-449. PubMed ID: 29145713
[TBL] [Abstract][Full Text] [Related]
22. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters.
Papathanasiou ND; Du Y; Menezes LJ; Almuhaideb A; Shastry M; Beynon H; Bomanji JB
Br J Radiol; 2012 Jun; 85(1014):e188-94. PubMed ID: 21385914
[TBL] [Abstract][Full Text] [Related]
23. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis.
Danve A; O'Dell J
Int J Rheum Dis; 2015 Sep; 18(7):714-24. PubMed ID: 26177990
[TBL] [Abstract][Full Text] [Related]
24. Three-dimensional fat-saturated T1-weighted Cartesian volumetric interpolated breath-hold examination (VIBE) for the diagnosis of aortitis in patients with suspected large vessel vasculitis: a comparative study with
Einspieler I; Henninger M; Mergen V; Wendorff H; Haller B; Eiber M; Rummeny EJ; Schwaiger M; Moog P; Thürmel K
Clin Radiol; 2019 Sep; 74(9):731.e11-731.e19. PubMed ID: 31130228
[TBL] [Abstract][Full Text] [Related]
25. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Tezuka D; Haraguchi G; Ishihara T; Ohigashi H; Inagaki H; Suzuki J; Hirao K; Isobe M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):422-9. PubMed ID: 22498333
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis of large-vessel vasculitis using [18F]-FDG PET-CT].
Rozzanigo U; Pellegrin A; Centonze M; Casagranda G; Erini M; Donner D
Radiol Med; 2013 Jun; 118(4):633-47. PubMed ID: 23184243
[TBL] [Abstract][Full Text] [Related]
27. Imaging features of
Chen Z; Zhao Y; Wang Q; Li Y; Li H; Zhou Y
Clin Rheumatol; 2022 May; 41(5):1499-1509. PubMed ID: 35088208
[TBL] [Abstract][Full Text] [Related]
28. The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis.
Webb M; Chambers A; AL-Nahhas A; Mason JC; Maudlin L; Rahman L; Frank J
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):627-34. PubMed ID: 14730404
[TBL] [Abstract][Full Text] [Related]
29. Disease activity and vascular involvement in retroperitoneal fibrosis: first experience with fully integrated 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging compared to clinical and laboratory parameters.
Thuermel K; Einspieler I; Wolfram S; Moog P; Meier R; Schwaiger M; Heemann U
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):146-154. PubMed ID: 27974103
[TBL] [Abstract][Full Text] [Related]
30. [(18)F]fluorodeoxyglucose PET in large vessel vasculitis.
Walter MA
Radiol Clin North Am; 2007 Jul; 45(4):735-44, viii. PubMed ID: 17706537
[TBL] [Abstract][Full Text] [Related]
31. The value of
Schönau V; Vogel K; Englbrecht M; Wacker J; Schmidt D; Manger B; Kuwert T; Schett G
Ann Rheum Dis; 2018 Jan; 77(1):70-77. PubMed ID: 28928271
[TBL] [Abstract][Full Text] [Related]
32. Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with 18F-FDG PET.
Webb M; Al-Nahhas A
Nucl Med Commun; 2006 Jul; 27(7):547-9. PubMed ID: 16794514
[No Abstract] [Full Text] [Related]
33. F-18 FDG PET for assessment of disease activity of large vessel vasculitis: A systematic review and meta-analysis.
Lee SW; Kim SJ; Seo Y; Jeong SY; Ahn BC; Lee J
J Nucl Cardiol; 2019 Feb; 26(1):59-67. PubMed ID: 30120746
[TBL] [Abstract][Full Text] [Related]
34. (18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.
Lavado-Pérez C; Martínez-Rodríguez I; Martínez-Amador N; Banzo I; Quirce R; Jiménez-Bonilla J; De Arcocha-Torres M; Bravo-Ferrer Z; Jiménez-Alonso M; López-Defilló JL; Blanco R; González-Gay MA; Carril JM
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):275-81. PubMed ID: 26159505
[TBL] [Abstract][Full Text] [Related]
35. Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.
Lensen KD; Comans EF; Voskuyl AE; van der Laken CJ; Brouwer E; Zwijnenburg AT; Pereira Arias-Bouda LM; Glaudemans AW; Slart RH; Smulders YM
Biomed Res Int; 2015; 2015():914692. PubMed ID: 25695092
[TBL] [Abstract][Full Text] [Related]
36. Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data.
Belhocine T; Blockmans D; Hustinx R; Vandevivere J; Mortelmans L
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1305-13. PubMed ID: 12811529
[TBL] [Abstract][Full Text] [Related]
37. The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with takayasu arteritis.
Lee KH; Cho A; Choi YJ; Lee SW; Ha YJ; Jung SJ; Park MC; Lee JD; Lee SK; Park YB
Arthritis Rheum; 2012 Mar; 64(3):866-75. PubMed ID: 21989701
[TBL] [Abstract][Full Text] [Related]
38. Association of
Quinn KA; Ahlman MA; Alessi HD; LaValley MP; Neogi T; Marko J; Novakovich E; Grayson PC
Arthritis Rheumatol; 2023 Jan; 75(1):98-107. PubMed ID: 35792044
[TBL] [Abstract][Full Text] [Related]
39. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI.
Meller J; Strutz F; Siefker U; Scheel A; Sahlmann CO; Lehmann K; Conrad M; Vosshenrich R
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):730-6. PubMed ID: 12677302
[TBL] [Abstract][Full Text] [Related]
40. Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy.
Nielsen BD; Gormsen LC; Hansen IT; Keller KK; Therkildsen P; Hauge EM
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1119-1128. PubMed ID: 29671039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
